GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,640.50p
   
  • Change Today:
      4.50p
  • 52 Week High: 1,711.20p
  • 52 Week Low: 1,316.00p
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 5,015,380
  • Market Cap: £67,997m
  • RiskGrade: 129

Latest Deals

Traded Action Notifier PriceAmountValue
16-Apr-24 Buy Dividends Hal Barron 3,202.70p 2,906,213 £93,077,316.08
16-Apr-24 Buy Dividends Emma Walmsley 1,611.28p 1,840,922 £29,662,409.10
12-Apr-24 Buy Dividends Vishal Sikka 3,289.66p 43 £1,414.56
12-Apr-24 Buy Dividends Jesse Goodman 3,289.66p 9 £296.07
12-Apr-24 Buy Dividends Harry (Hal) C. Dietz 3,289.66p 9 £296.07
12-Apr-24 Buy Dividends Anne Beal 3,289.66p 9 £296.07
12-Apr-24 Buy Dividends Hal Barron 3,289.66p 13 £427.66
12-Apr-24 Buy Dividends Charles Bancroft 3,289.66p 68 £2,236.97
12-Apr-24 Buy Dividends Elizabeth (Liz) McKee Anderson 3,289.66p 11 £361.86
11-Apr-24 Buy Dividends Emma Walmsley 1,630.94p 24 £391.43
10-Apr-24 Transfer From Julie Brown 0.000p 7 £0.00
10-Apr-24 Buy Julie Brown 1,612.77p 7 £112.89
10-Apr-24 Transfer From Emma Walmsley 0.000p 8 £0.00
10-Apr-24 Buy Emma Walmsley 1,612.77p 8 £129.02
20-Mar-24 Buy Vishal Sikka 1,638.72p 378 £6,194.36
20-Mar-24 Buy Elizabeth (Liz) McKee Anderson 1,638.72p 438 £7,177.59
20-Mar-24 Buy Jesse Goodman 1,638.72p 438 £7,177.57
20-Mar-24 Buy Harry (Hal) C. Dietz 1,638.72p 438 £7,177.57
20-Mar-24 Buy Anne Beal 1,638.72p 438 £7,177.57
20-Mar-24 Buy Hal Barron 1,638.72p 438 £7,177.59

Latest Notification of Holdings

No notifications of holding were found in the last 365 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,640.50p
Change Today 4.50p
% Change 0.28 %
52 Week High 1,711.20p
52 Week Low 1,316.00p
Volume 5,015,380
Shares Issued 4,144.88m
Market Cap £67,997m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80.47% below the market average80.47% below the market average80.47% below the market average80.47% below the market average80.47% below the market average
81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average81.13% below the sector average
Price Trend
29.70% above the market average29.70% above the market average29.70% above the market average29.70% above the market average29.70% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
44.11% above the market average44.11% above the market average44.11% above the market average44.11% above the market average44.11% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
24.54% below the market average24.54% below the market average24.54% below the market average24.54% below the market average24.54% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 25-Apr-2024

Time Volume / Share Price
16:35 1,722,703 @ 1,640.50p
16:35 157 @ 1,640.50p
16:35 395 @ 1,640.50p
16:35 474 @ 1,640.50p
16:35 2,215 @ 1,640.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page